Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up ☆

Bibliographic Details
Main Authors: Bellmunt, J. (Author), Comperat, E. (Author), De Santis, M. (Author), ESMO Guidelines Committee (Author), Gillessen, S. (Author), Huddart, R. (Author), Loriot, Y. (Author), Necchi, A. (Author), Powles, T. (Author), Ravaud, A. (Author), Shariat, S.F (Author), Szabados, B. (Author), Valderrama, B.P (Author), van der Heijden, M.S (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
antibody conjugate
antibody drug conjugates
bladder cancer
bladder tumor
Carcinoma, Transitional Cell
fibroblast growth factor receptor inhibitors
follow up
Follow-Up Studies
human
Humans
immune checkpoint inhibitors
Immunoconjugates
platinum-based chemotherapy
practice guideline
transitional cell carcinoma
Urinary Bladder Neoplasms
urothelial carcinoma
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items